PMCCPMCCPMCC

Search tips
Search criteria 

Advanced

 
Logo of jrsocmedLink to Publisher's site
 
J R Soc Med. 1998; 91(Suppl 34): 25–29.
PMCID: PMC1296370

Systematic review of nebulized antibiotics in cystic fibrosis: evolution of protocol.

Full text

Full text is available as a scanned copy of the original print version. Get a printable copy (PDF file) of the complete article (733K), or click on a page image below to browse page by page. Links to PubMed are also available for Selected References.

Selected References

These references are in PubMed. This may not be the complete list of references from this article.
  • Pitcher-Wilmott RW, Levinsky RJ, Gordon I, Turner MW, Matthew DJ. Pseudomonas infection, allergy, and cystic fibrosis. Arch Dis Child. 1982 Aug;57(8):582–586. [PMC free article] [PubMed]
  • Hodson ME, Penketh AR, Batten JC. Aerosol carbenicillin and gentamicin treatment of Pseudomonas aeruginosa infection in patients with cystic fibrosis. Lancet. 1981 Nov 21;2(8256):1137–1139. [PubMed]
  • Mukhopadhyay S, Singh M, Cater JI, Ogston S, Franklin M, Olver RE. Nebulised antipseudomonal antibiotic therapy in cystic fibrosis: a meta-analysis of benefits and risks. Thorax. 1996 Apr;51(4):364–368. [PMC free article] [PubMed]
  • Mukhopadhyay S, Staddon GE, Eastman C, Palmer M, Davies ER, Carswell F. The quantitative distribution of nebulized antibiotic in the lung in cystic fibrosis. Respir Med. 1994 Mar;88(3):203–211. [PubMed]
  • Ilowite JS, Gorvoy JD, Smaldone GC. Quantitative deposition of aerosolized gentamicin in cystic fibrosis. Am Rev Respir Dis. 1987 Dec;136(6):1445–1449. [PubMed]
  • Mendelman PM, Smith AL, Levy J, Weber A, Ramsey B, Davis RL. Aminoglycoside penetration, inactivation, and efficacy in cystic fibrosis sputum. Am Rev Respir Dis. 1985 Oct;132(4):761–765. [PubMed]
  • Lefebvre C. The Cochrane Collaboration: the role of the UK Cochrane Centre in identifying the evidence. Health Libr Rev. 1994 Dec;11(4):235–242. [PubMed]
  • Pitcher-Wilmott RW, Levinsky RJ, Gordon I, Turner MW, Matthew DJ. Pseudomonas infection, allergy, and cystic fibrosis. Arch Dis Child. 1982 Aug;57(8):582–586. [PMC free article] [PubMed]
  • Fuchs HJ, Borowitz DS, Christiansen DH, Morris EM, Nash ML, Ramsey BW, Rosenstein BJ, Smith AL, Wohl ME. Effect of aerosolized recombinant human DNase on exacerbations of respiratory symptoms and on pulmonary function in patients with cystic fibrosis. The Pulmozyme Study Group. N Engl J Med. 1994 Sep 8;331(10):637–642. [PubMed]
  • Mulherin D, Ward K, Coffey M, Keogan MT, FitzGerald M. Cystic fibrosis in adolescents and adults. Ir Med J. 1991 Dec;84(4):121–124. [PubMed]
  • Schulz KF, Chalmers I, Hayes RJ, Altman DG. Empirical evidence of bias. Dimensions of methodological quality associated with estimates of treatment effects in controlled trials. JAMA. 1995 Feb 1;273(5):408–412. [PubMed]

Articles from Journal of the Royal Society of Medicine are provided here courtesy of Royal Society of Medicine Press